The Business Research Company’s Neurostimulation Devices Global Market Report 2021: COVID 19 Impact And Recovery
LONDON, GREATER LONDON, UK, August 6, 2021 /EINPresswire.com/ — According to the new market research report ‘Neurostimulation Devices Global Market Report 2021: COVID-19 Impact And Recovery To 2030’ published by The Business Research Company, the neurostimulation devices market is expected to grow from $5.77 billion in 2020 to $6.59 billion in 2021 at a compound annual growth rate (CAGR) of 14.2%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $9.92 billion in 2025 at a CAGR of 10.8%. The rising geriatric population across the globe is driving the growth of the neurostimulation device market.
Request For A Sample For The Global Neurostimulation Devices Market Report:
The neurostimulation devices market consists of sales of surgically or externally placed neurostimulators and related services. The neurostimulation devices are designed to deliver electrical stimulation to specific parts of the patient’s brain, spinal cord, or peripheral nervous system for the treatment of various conditions such as chronic pain, movement disorders, epilepsy, and Parkinson’s disease. The neurostimulation devices include spinal cord stimulators, deep brain stimulators, sacral nerve stimulators, vagus nerve stimulators, and cortical stimulators.
Trends In The Global Neurostimulation Devices Market
Minimally invasive treatments are being developed for the treatment of various neurological disorders. The neurostimulation devices are being innovated in a way to cause minimum invasion during neurological treatments. For example, Deep Brain Stimulation (DBS) is a minimally invasive surgical procedure to treat neurological symptoms of Parkinson’s disease, including tremors, rigidity, and movement control. DBS uses a neurostimulation device, similar to a heart pacemaker, to deliver electrical pulses to a very precise location in the brain circuits that influence Parkinson’s disease symptoms. The electrical pulses from the DBS device block the activity of these circuits so the rest of the brain can function more normally.
Global Neurostimulation Devices Market Segments:
The global neurostimulation devices market is further segmented based on type, application, end user, implantable devices, external devices and geography.
By Product: Implantable Devices, External Devices
By Application: Pain Management, Epilepsy, Essential Tremor, Urinary and Fecal Incontinence, Depression, Dystonia, Gastroparesis, Parkinson’s Disease
By End User: Hospitals, Rehabilitation Centers, Medical Clinic
By Implantable Devices: Cochlear Implants, Deep Brain Stimulation, Spinal Cord Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Gastric Electric Stimulation
By External Devices: Transcranial Magnetic Stimulation (TMS), Transcutaneous Electrical Nerve Stimulation (TENS)
By Geography: The global neurostimulation devices market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.
Read More On The Report For The Global Neurostimulation Devices Market At:
Neurostimulation Devices Global Market Report 2021 is one of a series of new reports from The Business Research Company that provides neurostimulation devices global market overviews, analyzes and forecasts global market size and growth for the global neurostimulation devices market, neurostimulation devices global market share, neurostimulation devices market players, neurostimulation devices market segments and geographies, neurostimulation devices market’s leading competitors’ revenues, profiles and market shares. The neurostimulation devices market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Read Neurostimulation Devices Global Market Report 2021 from The Business Research Company for information on the following:
Data Segmentations: Market Size, Global, By Region And By Country; Historic And Forecast Size, And Growth Rates For The World, 7 Regions And 12 Countries
Neurostimulation Devices Market Organizations Covered: Medtronic, Cyberonics, Boston Scientific Corporation, St. Jude Medical, Nevro Corporation.
Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Interested to know more about The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets. Here is a list of reports from The Business Research Company similar to the Neurostimulation Devices Global Market Report 2021:
Sterilization Equipment And Disinfectants Market – Opportunities And Strategies – Global Forecast To 2023
Portable Ultrasound Devices Market – Opportunities And Strategies – Global Forecast To 2022
Portable X-Ray Devices Market – By Segments (Mobile X-Ray Devices, Handheld X-Ray Devices), By Types (Computed Radiography X-Ray Devices, Digital X-Ray Devices And Analog X-Ray), And By Region, Opportunities And Strategies – Global Forecast To 2022
Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293